Katie Cooper
Director of Marketing
Replay available
Inuvo, Inc. (AMEX: INUV) Q1 2025 earnings conference call, held 2025-05-09. Replay captured from the company's public earnings webcast.

Director of Marketing
Analyst, Alliance Global Partners
Analyst, HC Wainwright
Chief Financial Officer
Analyst, Lindenburg
Analyst, Maxine Group
Chief Executive Officer
Ladies and gentlemen, and welcome to the Innovo Inc. First Quarter 2025 Earnings Call. At this time, note that all participant lines are in listen-only mode. But following the presentation, we will conduct a question and answer session. And if during this call you require immediate assistance, please press star zero for the operator. Also note that this call is being recorded on Friday, May 9, 2029. And I would like to turn the conference over to Katie Cooper, Director of Marketing. Please go ahead. Thank you, Operator, and good morning. I'd like to thank everyone for joining us today for the ANUVO first quarter 2025 shareholder update call. Today, ANUVO's Chief Executive Officer, Richard Howe, and Chief Financial Officer, Wally Ruiz, will be your presenters on the call. We would also like to remind our shareholders that we plan to file our 10Q with the Security and Exchange Commission this morning. Before we begin, I'm going to review the company's safe harbor statement. The statements in this conference call that are not descriptions of historical facts are forward-looking statements relating to the future events, and as such, all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. When used in the call, the words anticipate, could, enable, estimate, intend, expect, believe, potential, will, should, project, and similar expressions as they relate to a NUVO, Inc. are as such a forward-looking statement. Investors are cautioned that all forward-looking statements involve risk and uncertainties, which may cause actual results to differ from those anticipated by ANUVO at this time. In addition, other risks are more...